Loading fund overlap…
23 of 105 unique stocks in common · Jaccard: 21.9%
A weighted portfolio overlap of 35.93% indicates a moderate overlap (a meaningful shared core). This means that out of every ₹100 you invest across these two schemes, approximately ₹35.93 is allocated to the exact same companies at the same relative proportions. The schemes share 23 common holdings.
The largest overlapping asset in their portfolios is ICICI Bank, which commands a weight of 6.12% in SBI Dividend Yield Fund and 8.94% in SBI ELSS Tax Saver Fund. Holding both schemes increases your concentration in ICICI Bank rather than expanding your diversification.
If the overlap is above 30%, it is typically because both schemes benchmark to the same index (e.g. Nifty 50 or Nifty LargeMidcap 250) or overlap in their top large-cap picks. To improve your portfolio's diversification, consider allocating one of these tranches to a category with lower structural correlation (such as a mid-cap, small-cap, or international equity fund).
| Stock | in SBI Dividend | in SBI ELSS |
|---|---|---|
| ICICI BankBanks | 6.12% | 8.94% |
| State Bank of IndiaBanks | 4.20% | 3.62% |
| Larsen & ToubroConstruction | 4.08% | 2.99% |
| Tata Consultancy ServicesIT - Software | 3.06% | 2.08% |
| Kotak Mahindra BankBanks | 2.03% | 5.93% |
| Oil & Natural Gas CorporationOil | 2.63% | 1.89% |
| Axis BankBanks | 2.17% | 1.86% |
| Tech MahindraIT - Software | 1.95% | 1.81% |
| Tata SteelFerrous Metals | 1.68% | 4.12% |
| GAIL (India)Gas | 2.97% | 1.41% |
| Asian PaintsConsumer Durables | 1.61% | 1.37% |
| Bharti AirtelTelecom - Services | 1.32% | 1.81% |
| Cholamandalam Investment and Finance CompanyFinance | 2.11% | 1.29% |
| Grindwell NortonIndustrial Products | 1.49% | 1.13% |
| InfosysIT - Software | 3.00% | 1.00% |
| Britannia IndustriesFood Products | 1.35% | 0.79% |
| Aurobindo PharmaPharmaceuticals & Biotechnology | 2.06% | 0.69% |
| JSW EnergyPower | 0.68% | 0.86% |
| Bank of BarodaBanks | 1.24% | 0.65% |
| BioconPharmaceuticals & Biotechnology | 1.70% | 0.56% |
| Sun Pharmaceutical IndustriesPharmaceuticals & Biotechnology | 1.95% | 0.55% |
| Sanofi Consumer HealthcarePharmaceuticals & Biotechnology | 1.05% | 0.22% |
| Timken IndiaIndustrial Products | 1.31% | 0.19% |
Weighted overlap = Σ min(weight in fund A, weight in fund B) across shared stocks, from each fund's latest public monthly portfolio (as on May 2026). Equity holdings only, ISIN-verified. Not investment advice.